Skip to main content
View Desktop Site
Log in
Menu
Toggle navigation
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Log in
Search form
Search
Home
companies
Atacand
Atacand
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Star Ledger, NJ
FDA
cancer
ARBs
Merck
Cozaar
Bristol-Myers Squibb
Avapro
Atacand
Benicar
Diovan
Micardis
Teveten
AstraZeneca to pay Merck $647M for drug interests
AstraZeneca to pay Merck $647M for drug interests
Yahoo/AP
AstraZeneca
Merck
partnerships
Atacand
Lexxel
Plendil
Entocort
Click here to subscribe to daily news headlines in your email inbox
